Rhytidectomy Market Size Worth $6.40 Billion By 2032 | CAGR: 9.2%

The global rhytidectomy market size is expected to reach USD 6.40 billion by 2032, according to a new study by Polaris Market Research. The report “Rhytidectomy Market Share, Size, Trends, Industry Analysis Report, By Type (Full Facelift, Mini Facelift); By Age Group; By Gender (Male, Female); By End-use (Hospital, Clinics, Others); By Region, And Segment Forecasts, 2023 - 2032” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Adoption of facelift procedures is highest in developed economies may be attributed to factors such as greater disposable income, cultural norms and preferences, and access to advanced medical technologies and skilled practitioners. It is important for anyone considering any type of cosmetic procedure to do their research, consult with qualified professionals, and weigh the risks and benefits before making any decisions.

South Korea is also a major market for rhytidectomy procedures, with a high demand for minimally invasive techniques such as thread lifts and fillers. According to the International Society of Aesthetic Plastic Surgery, South Korea ranked 2^nd in the world for the number of face-lift procedures performed, in 2020, after the U.S.

According to the ASPS, the most common facial procedures in the U.S, in 2021, were: Nose reshaping (Rhinoplasty): 352,325 procedures, Eyelid surgery (Blepharoplasty): 285,347 procedures, Facelift: 120,931 procedures, Forehead lift: 46,912 procedures, and Ear surgery (Otoplasty): 29,651 procedures, respectively. Similarly, for neck procedures, the most common ones are: Neck lift: 16,380 procedures, Liposuction: 8,729 procedures, and Chin augmentation: 6,715 procedures.

Do you have any questions? Would you like to request a sample or make an inquiry before purchasing this report? Simply click the link below: https://www.polarismarketresearch.com/industry-analysis/rhytidectomy-market/request-for-sample

In March 2021, Allergan launched the JUVÉDERM VOLUMA XC with TSK Steriglide cannula, an innovative product designed to provide a non-surgical facelift. The product is a combination of a hyaluronic acid-based dermal filler and a specially designed cannula, which allows for precise placement and controlled injection of the filler into the skin. This technique provides a more natural-looking lift and volumization of the cheeks and mid-face, without the need for surgery. Allergan is a well-known brand in the aesthetic market, with a wide range of products and services that cater to the growing demand for cosmetic procedures. The company's products are known for their high quality and effectiveness, and the launch of JUVÉDERM VOLUMA XC with TSK Steriglide cannula further strengthens its position in the market.

Rhytidectomy Market Report Highlights

• Full Facelift segment is anticipated to grow at a high CAGR over the forecast period owing to the popularity of cosmetic surgery options among female patients aged 40-54 years.
• Age range of 40-54 years is a significant demographic for facelift procedures. Patients in this age range often begin to experience signs of aging, such as fine lines, wrinkles, and loss of skin elasticity.
• Female sector holds the significant market share over the forecast period due to under greater societal pressure women to maintain a youthful appearance.
• Hospitals are a significant player in the rhytidectomy market, offering a range of cosmetic surgery services including facelifts.
• North America is expected to grow prominently over the projected period on with a high demand for cosmetic surgery procedures including facelifts.
• The global players include Plastic Surgery Center, USA Health, Plasticrio, and Asset Hospital.

Polaris Market Research has segmented the rhytidectomy market report based on type, age group, gender, end-use, and region:

Rhytidectomy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Full Facelift
• Mini Facelift

Rhytidectomy, Age Group Outlook (Revenue - USD Billion, 2019 - 2032)

• 30 - 39 Years
• 40 - 54 Years
• 55 - 69 Years
• 70 Years and Above

Rhytidectomy, Gender Outlook (Revenue - USD Billion, 2019 - 2032)

• Male
• Female

Rhytidectomy, End Use Outlook (Revenue - USD Billion, 2019 - 2032)

• Hospitals
• Clinics
• Others

Rhytidectomy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America

• U.S.
• Canada

• Europe

• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands

• Asia Pacific

• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia

• Latin America

• Argentina
• Brazil
• Mexico

• Middle East & Africa

• UAE
• Saudi Arabia
• Israel
• South Africa